YiQi GuBen formula alleviates airway inflammation and airway remodeling in OVA-induced asthma mice through TLR4/NF-κB signaling pathway.
Yibu KongZhongtian WangHongjun YuAiai DongYongfu SongLei GuoJinpu ZhuLiping SunYinan GuoPublished in: The Journal of pharmacy and pharmacology (2024)
YQGB exhibits the anti-asthma effect by reducing airway inflammation and airway remodeling through suppressing TLR4/NF-κB signaling pathway, and is worth promoting clinically.
Keyphrases
- signaling pathway
- pi k akt
- toll like receptor
- chronic obstructive pulmonary disease
- lung function
- inflammatory response
- induced apoptosis
- epithelial mesenchymal transition
- immune response
- allergic rhinitis
- high glucose
- diabetic rats
- high fat diet induced
- mouse model
- cystic fibrosis
- type diabetes
- human milk
- endothelial cells
- metabolic syndrome
- cell proliferation
- insulin resistance
- preterm infants
- skeletal muscle